MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

MANP in African Americans With Hypertension

Phase 1

Withdrawn

Conditions: Hypertension, Resistant to Conventional Therapy

Interventions: Drug: Placebo - 1st Cycle
Drug: MANP - 2nd Cycle
Drug: MANP - 1st Cycle

First Posted Date: 2020-09-09

Last Posted Date: 2023-03-09

Lead Sponsor: Mayo Clinic

Registration Number: NCT04542681

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

Phase 1

Completed

Conditions: Cancer

Interventions: Diagnostic Test: PET/CT
Drug: radioactive drug (tracer)

First Posted Date: 2020-09-04

Last Posted Date: 2023-09-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 6

Registration Number: NCT04538950

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes

Phase 2

Active, not recruiting

Conditions: Covid19
SARS-CoV Infection

Interventions: Drug: Fisetin
Drug: Placebo

First Posted Date: 2020-09-03

Last Posted Date: 2024-07-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT04537299

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

First Responder Resiliency Program During COVID-19

Not Applicable

Completed

Conditions: Stress
Resilience
Sleep

Interventions: Behavioral: Resilience Program

First Posted Date: 2020-09-02

Last Posted Date: 2024-05-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 10

Registration Number: NCT04536376

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer

Phase 1

Completed

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8

Interventions: Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Biological: Therapeutic Autologous Platelet-rich Plasma

First Posted Date: 2020-09-01

Last Posted Date: 2024-04-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT04535323

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity

Not Applicable

Recruiting

Conditions: Upper Body Obesity

Interventions: Other: Exercise

First Posted Date: 2020-08-31

Last Posted Date: 2024-03-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT04532814

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Intraoperative Brain Microdialysis to Assess Neuroinflammation in Epileptic Tissue Immediately Prior to Surgical Resection.

Not Applicable

Conditions: Epilepsy

Interventions: Procedure: Intraoperative brain microdialysis

First Posted Date: 2020-08-28

Last Posted Date: 2024-07-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 3

Registration Number: NCT04531722

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

Recruiting

Conditions: Nucleotide Repeat Disease
Spinocerebellar Ataxias
Cerebellar Ataxia

Interventions: Other: Specimen collection

First Posted Date: 2020-08-27

Last Posted Date: 2024-10-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1000

Registration Number: NCT04529252

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face

Phase 2

Recruiting

Conditions: Topical and Infiltration Anesthetic Toxicity
Anesthesia, Local
Photodamaged Skin

Interventions: Drug: 7.5 g lidocaine 2.5%/ prilocaine 2.5% cream with occlusion
Drug: 2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion

First Posted Date: 2020-08-24

Last Posted Date: 2024-04-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 32

Registration Number: NCT04523961

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

A Vaccine (MV-s-NAP) for the Treatment of Patients with Invasive Metastatic Breast Cancer

Phase 1

Recruiting

Conditions: Anatomic Stage IV Breast Cancer AJCC V8
Invasive Breast Carcinoma
Metastatic Breast Adenocarcinoma
Recurrent Breast Carcinoma
Stage IV Breast Cancer AJCC V6 and V7

Interventions: Biological: Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Biopsy
Procedure: Biospecimen Collection

First Posted Date: 2020-08-21

Last Posted Date: 2024-10-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT04521764

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy